sma cure

Spinal muscular atrophy stakeholders rolled up their sleeves and dug into the status of therapy development at a National Institutes of Health meeting

posted on November 4, 2010 - 9:58am

In a sign of the significant progress being made in spinal muscular atrophy (SMA) research, the National Institutes of Health (NIH) convened a meeting in October that examined the status of laboratory research, clinical trials and strategies for drug development in this disease, with an eye toward speeding the process.